Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-10-10

FDA Approved: TACROLIMUS — Original Application (Encube Ethicals, Inc.)

View source ↗

Summary

FDA approved Encube Ethicals, Inc.'s tacrolimus ointment 0.1% as a generic product for the treatment of atopic dermatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tacrolimus Ointment (0.1%) (tacrolimus)

Snippet

ORIG AP for TACROLIMUS (TACROLIMUS OINTMENT 0.1%)